JP2012236849A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012236849A5 JP2012236849A5 JP2012174860A JP2012174860A JP2012236849A5 JP 2012236849 A5 JP2012236849 A5 JP 2012236849A5 JP 2012174860 A JP2012174860 A JP 2012174860A JP 2012174860 A JP2012174860 A JP 2012174860A JP 2012236849 A5 JP2012236849 A5 JP 2012236849A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- medicament
- glp
- composition according
- obesity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012174860A JP2012236849A (ja) | 2007-04-03 | 2012-08-07 | ジペプチジルペプチダーゼ４阻害化合物と甘味料との併用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90747107P | 2007-04-03 | 2007-04-03 | |
| JP2007097079 | 2007-04-03 | ||
| JP2007097079 | 2007-04-03 | ||
| US60/907,471 | 2007-04-03 | ||
| JP2012174860A JP2012236849A (ja) | 2007-04-03 | 2012-08-07 | ジペプチジルペプチダーゼ４阻害化合物と甘味料との併用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009507560A Division JP5616630B2 (ja) | 2007-04-03 | 2008-04-03 | ジペプチジルペプチダーゼ４阻害化合物と甘味料との併用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012236849A JP2012236849A (ja) | 2012-12-06 |
| JP2012236849A5 true JP2012236849A5 (OSRAM) | 2013-06-13 |
Family
ID=39808393
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009507560A Expired - Fee Related JP5616630B2 (ja) | 2007-04-03 | 2008-04-03 | ジペプチジルペプチダーゼ４阻害化合物と甘味料との併用 |
| JP2012174860A Pending JP2012236849A (ja) | 2007-04-03 | 2012-08-07 | ジペプチジルペプチダーゼ４阻害化合物と甘味料との併用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009507560A Expired - Fee Related JP5616630B2 (ja) | 2007-04-03 | 2008-04-03 | ジペプチジルペプチダーゼ４阻害化合物と甘味料との併用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8927504B2 (OSRAM) |
| EP (1) | EP2143443B1 (OSRAM) |
| JP (2) | JP5616630B2 (OSRAM) |
| KR (2) | KR20120030570A (OSRAM) |
| CN (2) | CN103330939A (OSRAM) |
| AU (1) | AU2008233548B2 (OSRAM) |
| CA (1) | CA2682736C (OSRAM) |
| ES (1) | ES2529149T3 (OSRAM) |
| WO (1) | WO2008120813A1 (OSRAM) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| SG174054A1 (en) | 2006-05-04 | 2011-09-29 | Boehringer Ingelheim Int | Polymorphs |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| KR20120030570A (ko) * | 2007-04-03 | 2012-03-28 | 미쓰비시 타나베 파마 코퍼레이션 | 디펩티딜 펩티다아제 4 저해 화합물과 감미료와의 병용 |
| CL2008002427A1 (es) | 2007-08-16 | 2009-09-11 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2. |
| PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| BRPI0916997A2 (pt) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Inibidor de dpp-4 e seu uso |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| RU2011113823A (ru) | 2008-09-10 | 2012-10-20 | БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) | Комбинированная терапия, предназначенная для лечения диабета и связанных с ним состояний |
| WO2010039124A1 (en) * | 2008-09-30 | 2010-04-08 | Mitsubishi Tanabe Pharma Corporation | Benzenesulfonic acid salt compounds |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| EP2382216A1 (en) | 2008-12-23 | 2011-11-02 | Boehringer Ingelheim International GmbH | Salt forms of organic compound |
| AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
| SG173619A1 (en) | 2009-02-13 | 2011-09-29 | Boehringer Ingelheim Int | Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof |
| EP3646859A1 (en) | 2009-11-27 | 2020-05-06 | Boehringer Ingelheim International GmbH | Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin |
| JP5721232B2 (ja) * | 2009-12-04 | 2015-05-20 | 株式会社東洋新薬 | グルカゴン様ペプチド−１分泌促進剤 |
| JP5570244B2 (ja) * | 2010-02-23 | 2014-08-13 | 株式会社ヤクルト本社 | 腸間膜脂肪低減剤 |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| JP5561639B2 (ja) * | 2010-03-30 | 2014-07-30 | 静岡県公立大学法人 | Ｇｐｒ４３陽性・腸内分泌細胞増加促進剤 |
| NZ602921A (en) | 2010-05-05 | 2016-01-29 | Boehringer Ingelheim Int | Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor |
| US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| KR20230051307A (ko) | 2010-06-24 | 2023-04-17 | 베링거 인겔하임 인터내셔날 게엠베하 | 당뇨병 요법 |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| WO2012054523A2 (en) | 2010-10-19 | 2012-04-26 | Elcelyx Therapeutics, Inc. | Chemosensory receptor ligand-based therapies |
| AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| UY33937A (es) | 2011-03-07 | 2012-09-28 | Boehringer Ingelheim Int | Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina |
| AU2012285904C1 (en) | 2011-07-15 | 2017-08-31 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| US20130303462A1 (en) | 2012-05-14 | 2013-11-14 | Boehringer Ingelheim International Gmbh | Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome |
| EP4151218A1 (en) | 2012-05-14 | 2023-03-22 | Boehringer Ingelheim International GmbH | Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| WO2014064215A1 (en) | 2012-10-24 | 2014-05-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING β-CELL SURVIVAL |
| EP3110449B1 (en) | 2014-02-28 | 2023-06-28 | Boehringer Ingelheim International GmbH | Medical use of a dpp-4 inhibitor |
| EP3194416A4 (en) * | 2014-09-18 | 2018-02-14 | The Trustees of Columbia University in the City of New York | A neural substrate for sugar preference |
| EP3273981B1 (en) | 2015-03-24 | 2020-04-29 | INSERM - Institut National de la Santé et de la Recherche Médicale | Method and pharmaceutical composition for use in the treatment of diabetes |
| EP3468562A1 (en) | 2016-06-10 | 2019-04-17 | Boehringer Ingelheim International GmbH | Combinations of linagliptin and metformin |
| JP6842072B2 (ja) * | 2019-03-07 | 2021-03-17 | 物産フードサイエンス株式会社 | エガセラ属細菌の菌数抑制剤 |
| JP6765090B2 (ja) * | 2019-05-14 | 2020-10-07 | 株式会社東洋新薬 | 黒生姜含有組成物 |
| WO2021153718A1 (ja) * | 2020-01-31 | 2021-08-05 | 国立大学法人京都大学 | 線維芽細胞増殖因子２１誘導剤、及びアルコール嗜好性又は単純糖質嗜好性を抑制するための組成物 |
| JP2021161070A (ja) * | 2020-03-31 | 2021-10-11 | 花王株式会社 | Ｇｌｐ−１分泌促進剤 |
| JP2021161069A (ja) * | 2020-03-31 | 2021-10-11 | 花王株式会社 | 食後血中中性脂肪上昇抑制剤 |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5982313A (ja) | 1982-11-04 | 1984-05-12 | Meiji Seika Kaisha Ltd | 体内脂質減少剤 |
| JPH0665080A (ja) | 1992-03-10 | 1994-03-08 | Godo Shiyusei Kk | α−グルコシダ−ゼ阻害剤を含有する、過血糖付随疾患の予防・治療剤、および保健食 |
| IL111785A0 (en) | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
| DE19616486C5 (de) | 1996-04-25 | 2016-06-30 | Royalty Pharma Collection Trust | Verfahren zur Senkung des Blutglukosespiegels in Säugern |
| US20020006899A1 (en) | 1998-10-06 | 2002-01-17 | Pospisilik Andrew J. | Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals |
| TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
| JPH10290681A (ja) * | 1997-04-18 | 1998-11-04 | Suntory Ltd | 抗肥満作用を有する飲食品 |
| DE19823831A1 (de) | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| US6172081B1 (en) | 1999-06-24 | 2001-01-09 | Novartis Ag | Tetrahydroisoquinoline 3-carboxamide derivatives |
| US6107317A (en) | 1999-06-24 | 2000-08-22 | Novartis Ag | N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| US6110949A (en) | 1999-06-24 | 2000-08-29 | Novartis Ag | N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| GB9928330D0 (en) | 1999-11-30 | 2000-01-26 | Ferring Bv | Novel antidiabetic agents |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| GB0010183D0 (en) | 2000-04-26 | 2000-06-14 | Ferring Bv | Inhibitors of dipeptidyl peptidase IV |
| GB0010188D0 (en) | 2000-04-26 | 2000-06-14 | Ferring Bv | Inhibitors of dipeptidyl peptidase IV |
| TW583185B (en) | 2000-06-13 | 2004-04-11 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same |
| EP1930319B1 (en) | 2000-08-10 | 2012-05-02 | Mitsubishi Tanabe Pharma Corporation | Proline derivatives and use thereof as drugs |
| DK1325910T3 (da) | 2000-10-06 | 2008-11-10 | Mitsubishi Tanabe Pharma Corp | Aliphatiske nitrogenholdige femleddede ringforbindelser |
| CA2433090A1 (en) | 2000-12-27 | 2002-07-04 | Kyowa Hakko Kogyo Co., Ltd. | Dipeptidyl peptidase iv inhibitor |
| JP2002265439A (ja) | 2001-03-08 | 2002-09-18 | Mitsubishi Pharma Corp | シアノピロリジン誘導体およびその医薬用途 |
| EP1385508B1 (en) | 2001-03-27 | 2008-05-21 | Merck & Co., Inc. | Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| US20030031772A1 (en) * | 2001-03-28 | 2003-02-13 | Zehner Lee R. | Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glyemic index |
| US6573287B2 (en) | 2001-04-12 | 2003-06-03 | Bristo-Myers Squibb Company | 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method |
| GB0115517D0 (en) | 2001-06-25 | 2001-08-15 | Ferring Bv | Novel antidiabetic agents |
| US7196201B2 (en) | 2001-06-27 | 2007-03-27 | Smithkline Beecham Corporation | Pyrrolidines as dipeptidyl peptidase inhibitors |
| WO2003002553A2 (en) | 2001-06-27 | 2003-01-09 | Smithkline Beecham Corporation | Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| PL367527A1 (en) | 2001-06-27 | 2005-02-21 | Smithkline Beecham Corporation | Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| US20040259883A1 (en) | 2001-09-14 | 2004-12-23 | Hiroshi Sakashita | Thiazolidine derivative and medicinal use thereof |
| GB0125445D0 (en) | 2001-10-23 | 2001-12-12 | Ferring Bv | Protease Inhibitors |
| US6710040B1 (en) * | 2002-06-04 | 2004-03-23 | Pfizer Inc. | Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors |
| TW200401635A (en) | 2002-07-23 | 2004-02-01 | Yamanouchi Pharma Co Ltd | 2-Cyano-4-fluoropyrrolidine derivative or salt thereof |
| EA007613B1 (ru) | 2002-08-29 | 2006-12-29 | Тайсо Фармасьютикал Ко., Лтд. | Бензолсульфонатная соль (2s,4s)-1-циано-4-фтор-1-[(2-гидрокси-1,1-диметил)этиламино]ацетилпирролидина |
| US20040087514A1 (en) * | 2002-09-06 | 2004-05-06 | Hughes Thomas E | Nutritional compositions |
| JP2005170792A (ja) | 2002-11-22 | 2005-06-30 | Mitsubishi Pharma Corp | Ｌ−プロリン誘導体およびその医薬としての用途。 |
| KR100998796B1 (ko) | 2003-01-31 | 2010-12-06 | 가부시키가이샤산와카가쿠켄큐쇼 | 디펩티딜 펩티다아제 ｉｖ를 저해하는 화합물 |
| KR20050122220A (ko) | 2003-03-25 | 2005-12-28 | 다케다 샌디에고, 인코포레이티드 | 디펩티딜 펩티다제 억제제 |
| US7638638B2 (en) | 2003-05-14 | 2009-12-29 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| US6995183B2 (en) | 2003-08-01 | 2006-02-07 | Bristol Myers Squibb Company | Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods |
| CA2536251C (en) * | 2003-09-02 | 2009-08-04 | Merck & Co., Inc. | Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| US7790734B2 (en) * | 2003-09-08 | 2010-09-07 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| EP1697342A2 (en) | 2003-09-08 | 2006-09-06 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| EP1520486A1 (en) * | 2003-09-30 | 2005-04-06 | Tiense Suikerraffinaderij N.V. | Composition for suppressing ghrelin and method for same |
| TW200519105A (en) | 2003-10-20 | 2005-06-16 | Lg Life Science Ltd | Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| WO2005075426A1 (en) | 2004-02-03 | 2005-08-18 | Glenmark Pharmaceuticals Ltd. | Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof |
| CN101684089A (zh) | 2004-02-05 | 2010-03-31 | 杏林制药株式会社 | 双环酯类衍生物 |
| US7560569B2 (en) | 2004-02-18 | 2009-07-14 | Kyorin Pharmaceutical Co., Ltd | Bicycloamide derivative |
| US7514571B2 (en) | 2004-02-27 | 2009-04-07 | Kyorin Pharmaceutical Co., Ltd. | Bicyclo derivative |
| CN102079743B (zh) | 2004-03-15 | 2020-08-25 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
| BRPI0607863B8 (pt) | 2005-02-18 | 2021-05-25 | Mitsubishi Pharma Corp | sal cristalino 2,5-bromidrato de 3-{(2s,4s)-4-[4-(3-metil-1-fenil-1h-pirazol-5-il)piperazin-1-il]pirrolidin-2-ilcarbonil}tiazolidina e seu processo de preparo |
| WO2006090244A1 (en) | 2005-02-22 | 2006-08-31 | Glenmark Pharmaceuticals S.A. | New adamantane derivatives as dipeptidyl, peptidase iv inhibitors, processes for their preparation, and pharmaceutical compositions containing them |
| TWI357902B (en) | 2005-04-01 | 2012-02-11 | Lg Life Science Ltd | Dipeptidyl peptidase-iv inhibiting compounds, meth |
| MX2007011453A (es) | 2005-04-22 | 2008-02-12 | Alantos Pharmaceuticals Holding Inc | Inhibidores de la dipeptidil peptidasa-iv. |
| JP2007001946A (ja) * | 2005-06-24 | 2007-01-11 | Ono Pharmaceut Co Ltd | ピロリジン誘導体 |
| KR20120030570A (ko) * | 2007-04-03 | 2012-03-28 | 미쓰비시 타나베 파마 코퍼레이션 | 디펩티딜 펩티다아제 4 저해 화합물과 감미료와의 병용 |
-
2008
- 2008-04-03 KR KR1020127002221A patent/KR20120030570A/ko not_active Ceased
- 2008-04-03 CN CN2013102037612A patent/CN103330939A/zh active Pending
- 2008-04-03 KR KR1020097022913A patent/KR101361427B1/ko not_active Expired - Fee Related
- 2008-04-03 ES ES08739785.7T patent/ES2529149T3/es active Active
- 2008-04-03 CN CN2008800111647A patent/CN101652147B/zh not_active Expired - Fee Related
- 2008-04-03 JP JP2009507560A patent/JP5616630B2/ja not_active Expired - Fee Related
- 2008-04-03 US US12/594,568 patent/US8927504B2/en not_active Expired - Fee Related
- 2008-04-03 CA CA2682736A patent/CA2682736C/en not_active Expired - Fee Related
- 2008-04-03 EP EP08739785.7A patent/EP2143443B1/en not_active Not-in-force
- 2008-04-03 WO PCT/JP2008/056678 patent/WO2008120813A1/ja not_active Ceased
- 2008-04-03 AU AU2008233548A patent/AU2008233548B2/en not_active Ceased
-
2012
- 2012-08-07 JP JP2012174860A patent/JP2012236849A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012236849A5 (OSRAM) | ||
| JP2014528474A5 (OSRAM) | ||
| JP2010248252A5 (OSRAM) | ||
| WO2011005811A8 (en) | Combination therapy for the treatment of diabetes | |
| NI201100194A (es) | Derivados de tieno [2, 3 - b] piridina como inhibidores de la replicación viral | |
| MX339614B (es) | Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2. | |
| IL223783B (en) | Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine | |
| JP2014533680A5 (OSRAM) | ||
| WO2012125830A3 (en) | Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control | |
| MX336657B (es) | Prevencion de hipoglucemia en pacientes con diabetes sacarina de tipo 2. | |
| WO2012007159A3 (en) | Novel gastro-retentive dosage forms | |
| HRP20250615T1 (hr) | Tradipitant za upotrebu u liječenju gastropareze | |
| JP2013541583A5 (OSRAM) | ||
| JP2013166781A5 (OSRAM) | ||
| PH12015500653B1 (en) | Combination drug comprising gemigliptin and metformin, and method for the preparation thereof | |
| WO2017182873A3 (en) | Peptide-oligourea foldamer compounds and methods of their use | |
| JP2007119497A5 (OSRAM) | ||
| JP2011500589A5 (OSRAM) | ||
| JP2014513121A5 (OSRAM) | ||
| WO2009133470A3 (en) | Use of dronedarone alone or in combination for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level | |
| JP2017061488A5 (OSRAM) | ||
| PH12019502767A1 (en) | Oral pharmaceutical formulations of remogliflozin | |
| MX2010011193A (es) | Composicion farmaceutica liquida para el tratamiento y prevencion del dolor. | |
| WO2012163088A3 (zh) | 肾病和心脏病的治疗药物及其用途 | |
| RU2016144695A (ru) | Комплекс танната ситаглиптина |